(EMAILWIRE.COM, November 03, 2019 ) The global cell counting market is expected to grow from USD 8.29 billion in 2017 to USD 12.31 billion by 2023, at a CAGR of 6.8% from 2018 to 2023.

The major factors driving the growth of Cell Counting market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.

The consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728

The cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market.

North America is expected to account for the largest share of the cell counting market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell counting market. Moreover, a number of major global players are based in the US, owing to which, the US is a center for innovation in the cell counting market.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728

The prominent players in the global cell counting market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany).